Getinge (GETI B.ST) Stock Price
Getinge Price
Revenue has compounded at 5.3% per year over the past 19 years to 34.97 B SEK. Earnings per share have grown at 3.1% per year over the last 19 years. Getinge's net margin stands at 6.5%, down from 11.0% several years earlier. Getinge currently offers a dividend yield of about 1.84%. The payout ratio is around 55% of earnings. The dividend has grown at 4.7% per year over the past 19 years. Analysts set a median price target of 231.03 SEK, implying 7.6% below the current price. Of 14 analysts, 8 rate the stock a buy — an overall Buy consensus.
Getinge stock price
Getinge business model & stock analysis
Frequently asked questions about Getinge
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge AB is primarily active in the healthcare industry.
The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.
Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.
Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.
Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.
Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.
Analysts currently set an average price target of 238.81 SEK for the Getinge stock (median: 231.03 SEK), implying -4.5 % versus the latest price. The consensus is based on 14 analyst ratings.
14 analysts currently rate the Getinge stock: 8 recommend buying, 5 holding and 1 selling. For 2026, analysts expect Getinge to generate revenue of 35.26 B SEK and earnings per share of 12.89 SEK.
Converted at the current exchange rate, the Getinge share trades at 22.22 EUR (250.00 SEK).
The Getinge share (GETI B.ST) is listed on 9 stock exchanges, including: London (0GZV.L), SIX (Zürich) (GETIB.SW), Frankfurt (GTN.F), München (GTN.MU), Düsseldorf (GTN.DU), Stockholm (GETI B.ST).
Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.
The expected revenue of Getinge is 35.26 B SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Getinge is 3.51 B SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Getinge is currently 19.40. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Getinge stock.
The price-to-sales ratio (P/S) of Getinge is currently 1.93. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Getinge stock.
The Eulerpool Quality Score for Getinge is 4/10.
The ISIN of Getinge is SE0000202624. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Getinge is 889714. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Getinge is GETI B.ST. The ticker symbol is used to trade Getinge shares on the stock exchange.
Getinge stock
Getinge Peer Group
Getinge Ticker
Getinge FIGI
All fundamentals and in-depth analysis of Getinge
Our stock analysis for Getinge stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Getinge. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.